AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Feb, 16, 2023
$AVXL Nell (director business development at Anave... See more
Jan, 15, 2023
They would be able to provide medical writing, cop... See more
KALA
Kala Pharmaceuticals Inc
-9.01%
$16.65 - $15.15
Feb 7th 2023 - Mar 21st 2023
FSR
Fisker Inc
-28.83%
$8.15 - $5.80
Feb 7th 2023 - Mar 21st 2023
Mar, 20, 2023
This is a positive long-term development
Jan, 4, 2023
but positive developments should be announced thro... See more
Feb, 16, 2023
$AVXL Nell (director business development at Anavex) published an Instagram history today and wrote: “French biotech lunch meeting went well, they gave me the sweetest treats” . 🤔
Jan, 15, 2023
They would be able to provide medical writing, copy editing, and creative support (the latter for making figures) to the authors to expedite manuscript development and submission.
Jan, 12, 2023
every month new info and developments.
Dec, 14, 2022
$AVXL This is a very positive development IMO.
Oct, 14, 2022
$AVXL while it is a positive development to see the presentation, it still doesn't negate the fact that significant good news should be PRd soon after.
Dec, 28, 2022
Successful development and potential approval for KPI-012 will be a huge boost for the company.
Mar, 20, 2023
This is a positive long-term development
Jan, 4, 2023
but positive developments should be announced throughout the year! Partnership?
Nov, 17, 2022
We’ve challenged the old model of longer development timelines, reflecting our team’s agility and dedication to creating emotionally desirable vehicles with the newest, most unique, experience on our price range.
Nov, 2, 2022
Fisker PEAR development is progressing well.
Oct, 12, 2022
After reviewing the caliber of talent that Fisker has in software development (I used LinkedIn for research), I have zero concerns that it will be anything short of exceptional.